These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10851224)
1. Hypertension, diabetes mellitus, hypercholesterolemia, and endothelin B receptor-mediated renal nitric oxide release. Barton M; d'Uscio LV Circulation; 2000 Jun; 101(23):E228-9. PubMed ID: 10851224 [No Abstract] [Full Text] [Related]
2. Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney. Kakoki M; Hirata Y; Hayakawa H; Tojo A; Nagata D; Suzuki E; Kimura K; Goto A; Kikuchi K; Nagano T; Omata M Circulation; 1999 Mar; 99(9):1242-8. PubMed ID: 10069794 [TBL] [Abstract][Full Text] [Related]
3. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Hirata Y; Hayakawa H; Suzuki E; Kimura K; Kikuchi K; Nagano T; Hirobe M; Omata M Circulation; 1995 Feb; 91(4):1229-35. PubMed ID: 7850963 [TBL] [Abstract][Full Text] [Related]
4. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide. Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780 [TBL] [Abstract][Full Text] [Related]
5. Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension. Cediel E; Vázquez-Cruz B; Navarro-Cid J; de las Heras N; Sanz-Rosa D; Cachofeiro V; Lahera V Kidney Int Suppl; 2002 Dec; (82):S2-7. PubMed ID: 12410847 [TBL] [Abstract][Full Text] [Related]
6. Expression of endothelin receptors and nitric oxide synthase in the brain of stroke-prone spontaneously hypertensive rats with cerebral apoplexy. Sakurai-Yamashita Y; Yamashita K; Kataoka Y; Himeno A; Niwa M; Taniyama K Brain Res; 1997 May; 756(1-2):61-7. PubMed ID: 9187314 [TBL] [Abstract][Full Text] [Related]
8. The role of ETB receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443. Clozel M; Breu V FEBS Lett; 1996 Mar; 383(1-2):42-5. PubMed ID: 8612787 [TBL] [Abstract][Full Text] [Related]
9. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. Ivy DD; Kinsella JP; Abman SH J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146 [TBL] [Abstract][Full Text] [Related]
10. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. Conrad KP; Gandley RE; Ogawa T; Nakanishi S; Danielson LA Am J Physiol; 1999 May; 276(5):F767-76. PubMed ID: 10330059 [TBL] [Abstract][Full Text] [Related]
11. The role of endothelin-1 in circulatory changes during hypodynamic sepsis in the rat. Szalay L; Kaszaki J; Nagy S; Boros M Shock; 1998 Aug; 10(2):123-8. PubMed ID: 9721979 [TBL] [Abstract][Full Text] [Related]
12. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641 [TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Li L; Fink GD; Watts SW; Northcott CA; Galligan JJ; Pagano PJ; Chen AF Circulation; 2003 Feb; 107(7):1053-8. PubMed ID: 12600921 [TBL] [Abstract][Full Text] [Related]
14. Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension. Ni Z; Bemanian S; Kivlighn SD; Vaziri ND Kidney Int; 1998 Jul; 54(1):188-92. PubMed ID: 9648078 [TBL] [Abstract][Full Text] [Related]
15. Ethanol reduces the endothelin-B receptor-mediated increase in portal inflow resistance in the isolated, perfused canine liver. Faro F; Ferraz JG; Stella HJ; Faro R; Antunes E; Opgennorth TJ; Withrington PG; de Nucci G J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S284-6. PubMed ID: 9595460 [TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats. Dharmani M; Mustafa MR; Achike FI; Sim MK Eur J Pharmacol; 2007 Apr; 561(1-3):144-50. PubMed ID: 17320855 [TBL] [Abstract][Full Text] [Related]
17. Enhanced or repressed pressor responses to endothelin-1 or IRL-1620, respectively, in eNOS knockout mice. Labonté J; D'Orléans-Juste P J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S109-12. PubMed ID: 15838255 [TBL] [Abstract][Full Text] [Related]
18. Effects of endothelin receptor antagonists on endothelin-1 and inducible nitric oxide synthase genes in a rat endotoxic shock model. Hirata Y; Ishimaru S Clin Sci (Lond); 2002 Aug; 103 Suppl 48():332S-335S. PubMed ID: 12193116 [TBL] [Abstract][Full Text] [Related]
19. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Black SM; Johengen MJ; Soifer SJ Pediatr Res; 1998 Dec; 44(6):821-30. PubMed ID: 9853913 [TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor increases nitric oxide and endothelin production in rat aorta. Jiang ZS; Yang YZ; Zhao W; Pang YZ; Liu NK; Tang CS Sheng Li Xue Bao; 2000 Jun; 52(3):211-4. PubMed ID: 11956566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]